Michael D. Hambuchen, Ph.D.
Affiliations: | 2013 | Pharmacology | University of Arkansas for Medical Sciences, United States |
Area:
PharmacologyGoogle:
"Michael Hambuchen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| S. Michael Owens | grad student | 2013 | UAMS | |
| (Combination immunotherapy for early and continuous protection from methamphetamine pharmacological effects.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Berquist MD, McGill MR, Mazur A, et al. (2020) Effect of bile duct ligation-induced liver dysfunction on methamphetamine pharmacokinetics in male and female rats. Drug and Alcohol Dependence. 215: 108190 |
| Hay CE, Ewing LE, Hambuchen MD, et al. (2020) The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse. The Journal of Pharmacology and Experimental Therapeutics |
| McClenahan SJ, Kormos CM, Gunnell M, et al. (2019) Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats. Vaccine |
| Hambuchen MD, Berquist MD, Simecka CM, et al. (2019) Effect of Bile Duct Ligation-induced Liver Dysfunction on Methamphetamine Pharmacokinetics and Locomotor Activity in Rats. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques. 22: 301-312 |
| McClenahan SJ, Hambuchen MD, Simecka CM, et al. (2019) Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats. Drug and Alcohol Dependence. 195: 140-147 |
| Hay CE, Gonzalez GA, Ewing LE, et al. (2018) Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse. Plos One. 13: e0200060 |
| Hambuchen MD, Hendrickson HP, Gunnell MG, et al. (2017) The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats. Drug and Alcohol Dependence. 179: 347-354 |
| Hambuchen MD, Hendrickson HP, Owens SM. (2017) Chiral determination of 3,4-methylenedioxypyrovalerone enantiomers in rat serum. Analytical Methods : Advancing Methods and Applications. 9: 609-617 |
| Hambuchen MD, Rüedi-Bettschen D, Gunnell MG, et al. (2016) Chronic Treatment of (+)-Methamphetamine-Induced Locomotor Effects in Rats Using One or a Combination of Two High Affinity Anti-Methamphetamine Monoclonal Antibodies. Human Vaccines & Immunotherapeutics. 0 |
| Hambuchen MD, Carroll FI, Rüedi-Bettschen D, et al. (2015) Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response. Journal of Medicinal Chemistry. 58: 4665-77 |